News
USPSTF: Statin Use for Primary Prevention of Cardiovascular Disease
This recommendation replaces the one from 2008 on screening for lipid disorders in adults.
Your search for replac returned 604 results
Uncategorized
Product Defect Leads to Recall of Hormone Replacement Therapy
The recall was initiated due to a manufacturing defect.
News
FDA-Approved Carnexiv Provides New Option for Certain Epilepsy Patients
Carnexiv, an antiepileptic drug, is a short-term (≤7 days) intravenous (IV) replacement therapy for oral carbamazepine formulations in adults.
News
Pancreatic Enzyme Replacement Beneficial for Pancreatic Cancer Patients
Data on nutritional markers (body mass index [BMI], albumin, total cholesterol) were collected at baseline and then assessed at 16 weeks; change from baseline was compared between the two groups.
News
AACE Issues Statement on Testosterone Therapy and Cardiovascular Risk
The American Association of Clinical Endocrinologists (AACE) has issued a position statement questioning claims that testosterone replacement therapy (TRT) increases the risk of cardiovascular disease among users.
News
New Testosterone Replacement Therapy Approved for At-Home Self-Administration
Xyosted carries a Boxed Warning regarding blood pressure increases that may potentially increase the risk for major adverse cardiovascular events.
Safety Alerts and Recalls, Uncategorized
Heart Meds Recalled After Discovery of Possible Carcinogenic Impurity
As valsartan is used to treat various cardiovascular conditions including heart failure and hypertension, patients should continue to take their medications until they have a replacement product,
News
Zomacton Approved for Four Additional Pediatric Indications
Previously, the product was approved for growth failure in children due to inadequate endogenous growth hormone (GH) secretion and for the replacement of endogenous GH in adults with GH deficiency.
Uncategorized
Platelet Inhibitor Persantine to Be Discontinued
The decision to discontinue the product is business-related and not due to product safety or efficacy.
News
Nicorette mini Lozenge Returns
The nicotine replacement therapy, Nicorette mini Lozenge (GlaxoSmithKline Consumer Healthcare) has been made available again following a supply shortage caused by a recall last year.
